Octapharma offers pharmaceutical excipients for research and further manufacturing use, and is the largest privately owned, independent plasma fractionator in the world, with medicines consisting of high-quality human proteins sourced from human plasma and human cell lines. For more than 10 years, Octapharma has supported industrial customers worldwide.

No comments available.
Leave your rating & comment